-
WHO's Newest Updates in Pharmaceutical GMP Guidelines
Saher Binte Haider
April 23, 2024
GMP is a fundamental concept in pharmaceutical manufacturing and distribution. Poor-quality medicinal products can lead to adverse effects, treatment failure, and even death. Implementing GMP assures that pharmaceutical products are produced with the high
-
WHO Publishes Updated List of COVID-19 Medicines, APIs
SHEM OIRERE
May 05, 2023
The coronavirus disease 2019 (COVID-19) infections and deaths continue to be reported across the globe creating demand for more appropriate medicines and associated active pharmaceutical ingredients.
-
WHO Prequalifies Ethionamide for Indian firm
SHEM OIRERE
May 04, 2023
The World Health Organization (WHO) in early April 2023 pre-qualified ethionamide, manufactured by Indian pharmaceutical company, Micro Labs Limited.
-
How Africa, Asia could benefit from Ticagrelor’s WHO listing
SHEM OIRERE
April 19, 2023
Anglo-Swedish multinational pharmaceutical and biotechnology company, AstraZeneca Plc, has recently applied to World Health Organization for the inclusion of Ticagrelor.
-
Remdesivir ineffective against COVID-19? Perhaps it is not taken the right way
PharmaSources/Shanghai Xiaoyaoshi
January 07, 2021
Remdesivir ineffective against COVID-19? Has a bleak prospect?! Perhaps it is not taken the right way.
-
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
drugs.com
January 19, 2022
If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday.
-
WHO recommends two new drugs to treat patients with COVID-19
WorldPharmaNews
January 18, 2022
The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids...
-
WHO recommends GSK-Vir and Lilly’s drugs for Covid-19 treatment
Pharmaceutical-Technology
January 17, 2022
The World Health Organization (WHO) has recommended the use of two new drugs by GlaxoSmithKline (GSK) and Vir Biotechnology and Eli Lilly to treat Covid-19.
-
WHO recommends two new drugs to treat COVID-19
ExpressPharma
January 17, 2022
The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable they will be...
-
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron
ExpressPharma
January 13, 2022
The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that shots needed to be more effective in protecting against infection.